Top Markets
Coin of the day
Endymed Ltd Endymed Ltd

Endymed Ltd

ENDY
Pozycja w akcjach #31814
Endymed Ltd is a medical technology company focused on the global design,... Endymed Ltd is a medical technology company focused on the global design, development, and sale of energy-driven aesthetic treatment systems, catering to both professional practitioners and individual consumers. Its product offerings include the versatile EndyMed PRO, a platform capable of multiple applications. Another key product, PURE 2.0, provides professional-grade skin tightening, body contouring, and functional skin resurfacing. Furthermore, the firm leverages its proprietary 3DEEP radiofrequency technology to deliver a wide array of solutions for cosmetic enhancements, such as diminishing wrinkles, tightening skin, sculpting the body, improving texture, reducing cellulite and overall circumference, treating acne and related scarring, lessening stretch marks, performing RF microneedling, and fractional resurfacing. Established in 2007, the company is headquartered in Freehold, New Jersey.
Cena akcji
$0.90225185
Ostatnia synchronizacja: 2025-02-16
Kapitalizacja rynkowa
$11.99M
Zmiana (1 dzień)
0.48%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Endymed Ltd (ENDY)

Kategoria

Zyski dla Endymed Ltd (ENDY)
Zyski w Sep 2024 TTM: $-2.02M
Według najnowszych raportów finansowych Endymed Ltd, obecny zysk firmy wynosi $-2.02M. W roku 2022 firma osiągnęła zysk w wysokości $1.71M, spadek w porównaniu do zysku z roku 2021, który wynosił $2.65M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Endymed Ltd od 2013 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
2026 (TTM) $-2.02M -291.90%
2023 $1.05M -38.42%
2022 $1.71M -35.68%
2021 $2.65M 760.71%
2020 $308.00K -82.36%
2019 $1.75M -13.61%
2018 $2.02M -174.82%
2017 $-2.70M -18.40%
2016 $-3.31M -13.58%
2015 $-3.83M -7,326.42%
2014 $53.00K -114.68%
2013 $-361.00K 0.00%
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
$7.51B -372,854.34%
US
$5.15B -255,583.87%
US
$5.56B -276,179.40%
IE
$3.86B -191,712.90%
US
$1.42B -70,452.36%
US